Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECULIZUMAB vs EDARAVONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECULIZUMAB vs EDARAVONE: Safety Overview

Metric ECULIZUMAB EDARAVONE
Total FAERS Reports 44,190 3,762
Deaths Reported 4,626 1,137
Death Rate 10.5% 30.2%
Hospitalizations 12,421 495
Average Patient Age 42.6 yrs 65.0 yrs
% Female Patients 59.5% 41.5%
FDA Approval Date N/A Dec 23, 2024
Manufacturer Alexion Pharmaceuticals Inc. Gland Pharma Limited
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued